Comparative hypoglycemic and nephroprotective effects of tocotrienol rich fraction (TRF) from palm oil and rice bran oil against hyperglycemia induced nephropathy in type 1 diabetic rats

Chemico-Biological Interactions

Volumn 188, Issue 3, 2010, Pages 651-658

  Siddiqui, Shabeena ^a   Rashid Khan, Mohd ^a   Siddiqui, Waseem A ^a  

^a HAMDARD UNIVERSITY   (India)

Author keywords

Diabetic nephropathy; Hyperglycemia; Oxidative stress; Renal function; Tocotrienols

Indexed keywords

ALPHA TOCOTRIENOL; CATALASE; GLUCOSE; HEMOGLOBIN A1C; MALONALDEHYDE; NITRIC OXIDE; NITROGEN; PALM OIL; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID REACTIVE SUBSTANCE; UREA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; BLOOD ANALYSIS; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DRUG EFFECT; DRUG MECHANISM; FRACTIONATION; GLOMERULUS FILTRATION RATE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HYPERGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY FUNCTION TEST; MALE; NONHUMAN; OXIDATIVE STRESS; RAT; RENAL PROTECTION; RICE BRAN; TREATMENT DURATION; URINALYSIS;

ANIMALS; ANTIOXIDANTS; BLOOD GLUCOSE; BLOOD UREA NITROGEN; CREATININE; DIABETES MELLITUS, TYPE 1; DIABETIC NEPHROPATHIES; FASTING; HEMOGLOBIN A, GLYCOSYLATED; HYPERGLYCEMIA; HYPOGLYCEMIC AGENTS; KIDNEY; MALE; NITRIC OXIDE; OXIDATIVE STRESS; PLANT OILS; PROTEINURIA; RATS; RATS, WISTAR; TOCOTRIENOLS;

ANIMALIA; RATTUS; RATTUS NORVEGICUS;

EID: 78149468012     PISSN: 00092797     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cbi.2010.08.010     Document Type: Article

References (64)

1. Giugliano D., Ceriello A., Paolisso G. Oxidative stress and diabetic vascular complications. Diabetes Care 1996, 19:257-267.
2. Viberti G., Wiseman M.J., Pinto J.R., Messent J. Diabetic Nephropathy, Joslin's Diabetes Mellitus 1994, 691-737. Lea and Febiger, Philadelphia. C.R. Kahn, G.C. Weir (Eds.).
3. Parving H.H., Osterby R., Ritz E. Diabetic Nephropathy, The Kidney 2000, 1731-1773. WB Saunders Company, Philadelphia. B.M. Brenner, S. Levine (Eds.).
4. Kuhad A., Chopra K. Attenuation of diabetic nephropathy by tocotrienol: involvement of NFκB signaling pathway. Life Sci. 2009, 84:296-301.
5. Coimbra T.M., Janssen U., Grone H.J., Ostendorf T., Kunter U., Schmidt H., et al. Early events leading to renal injury in obese Zucker (fatty) rats with type II diabetes. Kidney Int. 2000, 57:167-182.
6. Nangaku M., Izuhara Y., Usuda N., Inagi R., Shibata T., Sugiyama S., et al. In a type 2 diabetic nephropathy rat model, the improvement of obesity by a low calorie diet reduces oxidative/carbonyl stress and prevents diabetic nephropathy. Nephrol. Dial. Transplant. 2005, 20:2661-2669.
7. Loon N.R. Diabetic kidney disease: preventing dialysis and transplantation. Clin. Diabetes 2003, 21:55-63.
8. Verzola D., Bertolotto M.B., Villaggio B., Ottonello L., Dallegri F., Frumento G., et al. Taurine prevents apoptosis induced by high ambient glucose in human tubule renal cells. J. Investig. Med. 2002, 50:443-451.
9. Allen D.A., Harwood S., Varagunam M., Raftery M.J., Yaqoob M.M. High glucose-induced oxidative stress causes apoptosis in proximal tubular epithelial cells and is mediated by multiple caspases. FASEB J. 2003, 17:908-910.
10. Ishii N., Ogawa Z., Suzuki K., Numakami K., Saruta T., Itoh H. Glucose loading induces DNA fragmentation in rat proximal tubular cells. Metabolism 1996, 45:1348-1353.
11. Ortiz A., Ziyadeh F.N., Neilson E.G. Expression of apoptosis-regulatory genes in renal proximal tubular epithelial cells exposed to high ambient glucose and in diabetic kidneys. J. Investig. Med. 1997, 45:50-56.
12. Mitsuhashi T., Nakayama H., Itoh T., Kuwajima S., Aoki S., Atsumi T., et al. Immunohistochemical detection of advanced glycation end products in renal cortex from STZ-induced diabetic rat. Diabetes 1993, 42:826-832.
13. Makino H., Shikata K., Kushiro M., Hironaka K., Yamasaki Y., Sugimoto H., et al. Roles of advanced glycation end-products in the progression of diabetic nephropathy. Nephrol. Dial. Transplant. 1996, 11(Suppl. 5):S76-80.
14. Jain S.K., McVie R., Jaramillo J.J., Palmer M., Smith T., Meachum Z.D., et al. The effect of modest vitamin E supplementation on lipid peroxidation products and other cardiovascular risk factors in diabetic patients. Lipids 1996, 31:S87-90.
15. Baliarsingh S., Beg Z.H., Ahmad J. The therapeutic impacts of tocotrienols in type 2 diabetic patients with hyperlipidemia. Atherosclerosis 2005, 182:367-374.
16. Vieira da Costa V.A., Vianna L.M. Effect of α-tocopherol supplementation on blood pressure and lipidic profile in streptozotocin-induced diabetes mellitus in spontaneously hypertensive rats. Clin. Chim. Acta 2005, 351:101-104.
17. Eshrat H.M., Mukhopadhyay A.K. Effect of ocimum sanctum (tulsi) and vitamin E on biochemical parameters and retinopathy in streptozotocin induced diabetic rats. Indian J. Clin. Biochem. 2006, 21:181-188.
18. Liu S., Lee I.M., Song Y., Denburgh M.V., Cook N.R., Manson J.E., et al. Vitamin E and risk of type 2 diabetes in the women's health study randomized controlled trial. Diabetes 2006, 55:2856-2862.
19. Theriault A., Chao J.T., Wang Q., Gapor A., Adeli K. Tocotrienol: a review of its therapeutic potential. Clin. Biochem. 1999, 32:309-319.
20. Qureshi A.A., Sami S.A., Khan F.A. Effects of stabilized rice bran, its soluble and fiber fractions on blood glucose levels and serum lipid parameters in humans with diabetes mellitus Types I and II. J. Nutr. Biochem. 2002, 13:175-187.
21. Fang F., Kang Z., Wong C. Vitamin E tocotrienols improve insulin sensitivity through activating peroxisome proliferator-activated receptors. Mol. Nutr. Food Res. 2010, 54:345-352.
22. Li F., Tan W., Kang Z., Wong C.W. Tocotrienol enriched palm oil prevents atherosclerosis through modulating the activities of peroxisome proliferators-activated receptors. Atherosclerosis 2010, (January). [Epub ahead of print].
23. Ng M.H., Choo Y.M., Ma A.N., Chuah C.H., Hashim M.A. Separation of Vitamin E (tocopherol, tocotrienol, and tocomonoenol) in palm oil. Lipids 2004, 39:1031-1035.
24. Budin J.T., Breene W.M., Putnam D.H. Some compositional properties of camelina (Camelina sativa L. Crantz) seeds and oils. J. Am. Oil Chem. Soc. 1995, 72:309-315.
25. Raghuram T.C., Rukmini C. Nutritional significance of rice bran oil. Indian J. Med. Res. 1995, 102:241-244.
26. Minhajuddin M., Beg Z.H., Iqbal J. Hypolipidemic and antioxidant properties of tocotrienol rich fraction isolated from rice bran oil in experimentally induced hyperlipidemic rats. Food Chem. Toxicol. 2005, 43:747-753.
27. Budin S.B., Othman F., Louis S.R., Bakar M.A., Das S., Mohamed J. The effects of palm oil tocotrienol-rich fraction supplementation on biochemical parameters, oxidative stress and vascular walls of streptozotocin-induced diabetic rats. Clinics 2009, 64:235-244.
28. Arreola-Mendoza L., Reyes J.L., Melendez E., Martin D., Namorado M.C., Sanchez E., et al. Alpha-tocopherol protects against the renal damage caused by potassium dichromate. Toxicology 2006, 218:237-246.
29. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 1976, 72:248-254.
30. Bories P.N., Bories C. Nitrate determination in biological fluids by an enzymatic one-step assay with nitrate reductase. Clin. Chem. 1995, 41(6 (Pt 1)):904-907.
31. Moshage H., Kok B., Huizenga J.R., Jansen P.L.M. Nitrite and nitrate determinations in plasma: a critical evaluation. Clin. Chem. 1995, 41(6 (Pt 1)):892-896.
32. Utley H.C., Bernheim F., Hochslein Effect of sulfhydryl reagent on peroxidation in microsome. Arch. Biochem. Biophys. 1967, 260:521-531.
33. Ohkawa H., Ohishi N., Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal. Biochem. 1979, 95:351-358.
34. Marklund S., Marklund G. Involvement of the superoxide anion radical in the auto oxidation of pyrogallol and a convenient assay for superoxide dismutase. Eur. J. Biochem. 1974, 47:469-474.
35. Claiborne A. Catalase Activity, Handbook of Methods for Oxygen Radical Research 1985, CRC Press, Boca Raton, pp. 283-284. R.A. Green Wald (Ed.).
36. Packer L., Weber S.U., Rimbach G. Molecular aspects of tocotrienol antioxidant action and cell signaling. J. Nutr. 2001, 131:S369-S373.
37. Traber M.G. Vitamin E regulatory mechanisms. Annu. Rev. Nutr. 2007, 27:347-362.
38. Nazaimoon W.M.W., Khalid B.A.K. Tocotrienols-rich diet decreases advanced glycosylation endproducts in non-diabetic rats and improves glycemic control in streptozotocin-induced diabetic rats. Malays. J. Pathol. 2002, 24:77-82.
39. Falk R.J., Scheinmman J.I., Mauer S.M., Michael A.F. Polyantigenic expression of basement membrane constituents of diabetic nephropathy. Diabetes 1983, 32(Suppl. 2):S34-S39.
40. Nerlich A., Schleicher E. Immunohistochemical localization of extracellular matrix components in human diabetic glomerular lesions. Am. J. Pathol. 1991, 139:889-899.
41. Sugimoto H., Shikata K., Wada J., Horiuchi S., Makino H. Advanced glycation end products-cytokine-nitric oxide sequence pathway in the development of diabetic nephropathy: aminoguanidine ameliorates the overexpression of tumour necrosis factor-alpha and inducible oxide synthase in diabetic rat glomeruli. Diabetologia 1999, 42:878-886.
42. Pennel J.P. Meinking TL Pattern of urinary proteins in experimental diabetes. Kidney Int. 1982, 21:709-713.
43. Maack T., Johnson V., Kau S.T., Figueiredo J., Sigulem D. Renal filtration, transport, and metabolism of low-molecular-weight proteins: a review. Kidney Int. 1979, 16:251-270.
44. Mogensen C.E. Kidney function and glomerular permeability in early juvenile diabetes. Scand. J. Clin. Lab. Invest. 1971, 28:79-90.
45. Chiarelli F., Verrotti A., Morgese G. Glomerular hyperfiltration increases the risk of developing microalbuminuria children. Pediatr. Nephrol. 1995, 9:154-158.
46. Vedel P., Obel J., Nielsen F.S. Glomerular hyperfiltration in microalbuminuric NIDDM patients. Diabetologia 1996, 39:1584-1589.
47. Tolins J.P., Plamer R.M.J., Moncada S., Raij L. Role of endothelium derived relaxing factor in regulation of renal hemodynamic responses. Am. J. Physiol. 1990, 258(3 (Pt 2)):H655-H662.
48. Bank N., Aynedjian H.S. Role of EDRF (nitric oxide) in diabetic renal hyperfiltration. Kidney Int. 1993, 43:1306-1312.
49. Maree A., Peer G., Iaina A., Wollman Y., Csernihovsky T., Silverberg D.S. Nitric oxide in streptozocin-induced diabetes mellitus in rats. Clin. Sci. 1996, 90:379-384.
50. Choi K.C., Lee S.C., Kim S.W., Kim N.H., Lee J.U., Kang Y.J. Role of nitric oxide in the pathogenesis of diabetic nephropathy in streptozotocin induced diabetic rats. Korean J. Intern. Medicine 1999, 14:32-41.
51. Apakkan Aksun S., Ozmen B., Ozmen D., Parildar Z., Senol B., Habif S., et al. Serum and urinary nitric oxide in Type 2 diabetes with or without microalbuminuria: relation to glomerular hyperfiltration. J. Diabetes Complicat. 2003, 17:343-348.
52. Kuhad A., Sachdeva A.K., Chopra K. Attenuation of renoinflammatory cascade in experimental model of diabetic nephropathy by sesamol. J. Agric. Food Chem. 2009, 57:6123-6128.
53. Komers R., Allen T.J., Cooper M.E. Role of endothelium derived nitric oxide in the pathogenesis of the renal hemodynamic changes of experimental diabetes. Diabetes 1994, 43:1190-1197.
54. Sugimoto H., Shikata K., Matsuda M., Hayashi Y., Hiragushi K., Wada J., et al. Increased expression of endothelial cell nitric oxide synthase (ec-NOS) in afferent and glomerular endothelial cells is involved in glomerular hyperfiltration of diabetic nephropathy. Diabetologia 1998, 41:1426-1434.
55. Wu S.J., Liu P.L., Ng L.T. Tocotrienol-rich fraction of palm oil exhibits anti-inflammatory property by suppressing the expression of inflammatory mediators in human monocytic cells. Mol. Nutr. Food Res. 2008, 52:921-929.
56. Craven P.A., Melhem M.F., DeRubertis F.R. Thromboxane in the pathogenesis of glomerular injury in diabetes. Kidney Int. 1992, 42:937-946.
57. Sharma S., Anjaneyulu M., Kulkarni S.K., Chopra K. Resveratrol: a polyphenolic phytoalexin, attenuates diabetic nephropathy in rats. Pharmacology 2006, 76:69-75.
58. Sharma S., Kulkarni S.K., Chopra K. Curcumin, the active principle of turmeric (Curcuma longa), ameliorates diabetic nephropathy in rats. Clin. Exp. Pharmacol. Physiol. 2006, 33:940-945.
59. Zhang W., Khanna P., Chan L.L., Campbell G., Ansari N.H. Diabetes-induced apoptosis in rat kidney. Biochem. Mol. Med. 1997, 61:58-62.
60. Murata I., Takemura G., Asano K., Sano H., Fujisawa K., Kagawa T., et al. Apoptotic cell loss following cell proliferation in renal glomeruli of Otsuka Long-Evans Tokushima Fatty rats, a model of human type 2 diabetes. Am. J. Nephrol. 2002, 22:587-595.
61. Suarna C., Hood R.L., Dean R.T., Stocker R. Comparative antioxidant activity of tocotrienols and other natural lipid-soluble antioxidants in a homogeneous system, and in rat and human lipoproteins. Biochim. Biophys. Acta 1993, 1166:163-170.
62. Kamal-Eldin A., Appelqvist L.A. The chemistry and antioxidant properties of tocopherols and tocotrienols. Lipids 1996, 31:671-701.
63. Serbinova E., Kagan V., Han D., Packer L. Free radical recycling and intramembrane mobility in the antioxidant properties of alpha-tocopherol and alpha-tocotrienol. Free Radic. Biol. Med. 1991, 10:263-275.
64. Serbinonva E.A., Packer L. Antioxidant properties of tocopherol and tocotrienol. Methods Enzymol. 1994, 234:354-367.